Skip to search formSkip to main contentSkip to account menu

menahydroquinone-4

Known as: MKH-4 cpd 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

HydroquinonesVitamin K 2
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Menahydroquinone-4 Prodrug: A Promising Candidate Anti-Hepatocellular Carcinoma Agent
Recently, new therapeutics have been developed for hepatocellular carcinoma (HCC). However, the overall survival rate of HCC… 
2004
2004
Vitamin K Prodrugs: 1. Synthesis of Amino Acid Esters of Menahydroquinone-4 and Enzymatic Reconversion to an Active Form
The efficacy and toxicity of vitamin K depends on the pathway and the extent of enzymatic reductive activation to vitamin K… 
1999
1999
Prodrug for bioreductive activation-independent delivery of menahydroquinone-4: human liver enzymatic activation and its action in warfarin-poisoned human liver.
The N,N-dimethylglycine esters of menahydroquinone-4 (1-mono, 1; 4-mono, 2; 1,4-bis, 3) were established in previous reports as… 
1995
1995
Vitamin K Prodrugs: 2. Water-Soluble Prodrugs of Menahydroquinone-4 for Systemic Site-Specific Delivery
AbstractPurpose. The hydrochloride salts of the N, N-dimethylglycine esters of menahydroquinone-4 (1-mono, 1; 4-mono, 2; and 1,4… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)